Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization.
Savani
Bipin N
BN
Dunbar
Cynthia E
CE
Rick
Margaret E
ME
D000328:Adult; D000741:Anemia, Aplastic / Q000150:complications* / Q000276:immunology / Q000628:therapy; D001787:Blood Group Incompatibility / Q000209:etiology / Q000276:immunology*; D001792:Blood Platelets / Q000276:immunology; D005167:Factor VII / Q000008:administration & dosage*; D015942:Factor VIIa; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D017713:Platelet Transfusion / Q000009:adverse effects* / Q000379:methods; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000209:etiology / Q000276:immunology*; D011994:Recombinant Proteins / Q000008:administration & dosage
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa